• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers

By: Investor Brand Network
April 02, 2025 at 10:05 AM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

A research team from the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh has developed a new diagnostic tool capable of profiling brain cancers in pediatric patients. Composed of pediatric neurosurgeons and researchers, the team designed a diagnostic platform that uses the body’s natural cancer-fighting immune response to classify pediatric brain tumors.

As pediatric cancer becomes easier to diagnose, the drugs being developed by enterprises like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) against central nervous system cancers stand a…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
ASML Q2 Earnings Call Highlights ↗
Today 2:02 EDT
Via MarketBeat
Topics Artificial Intelligence Earnings
Tickers ASML INTC
News headline image
Phoenix Education Partners Q3 Earnings Call Highlights ↗
July 14, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings Initial Public Offering
Tickers PXED
News headline image
Aehr Test Systems Q4 Earnings Call Highlights ↗
July 14, 2026
Via MarketBeat
Topics Artificial Intelligence Earnings
Tickers AEHR
News headline image
Kestra Medical Technologies Q4 Earnings Call Highlights ↗
July 14, 2026
Via MarketBeat
Topics Earnings
Tickers KMTS
News headline image
Syndax Pharmaceuticals Maps Growth Beyond Revuforj With Lung Cancer, Myelofibrosis Push ↗
July 14, 2026
Via MarketBeat
Tickers SNDX

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.49
+0.18 (0.07%)
AAPL  314.86
-2.45 (-0.77%)
AMD  548.13
+13.74 (2.57%)
BAC  60.62
+1.12 (1.88%)
GOOG  357.33
+6.66 (1.90%)
META  661.04
+4.31 (0.66%)
MSFT  384.93
-6.06 (-1.55%)
NVDA  211.80
+8.27 (4.06%)
ORCL  127.94
-3.60 (-2.74%)
TSLA  396.18
+1.42 (0.36%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap